Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs at Dexcom
San Diego, US
About
Matthew Dolan is Executive Vice President, Strategy, Corporate Development, and Dexcom Labs at DexCom Inc. a company that develops diabetic monitoring and managing systems. As the Senior Vice President, Dolan established a new division within Dexcom, which now exceeds 100 FTEs and includes three independent target segments. Matt Dolan initially served as DexCom, Inc.'s Vice President of Corporate Development, leading key partnerships with major players like Eli Lily. Beyond immediate success, he presented a long-term strategy to the board, focusing on core projects and emerging markets. His success resulted in a shift in corporate culture, leading to his current role as Senior Vice President and General Manager of New Markets. Matthew Dolan earned his Bachelor of Arts in Economics from Northwestern University. Today, Matthew Dolan leads the New Markets division, which he was instrumental in establishing. This division now encapsulates nearly 100 employees and covers multiple target m
Position in the VCSift Database
- • 4 investors at Dexcom are tracked.
- • 1 investors hold the Executive Vice President, Strategy, Corporate Development & Dexcom Labs role in VCSift. Matt Dolan is one of them.
- • 829 investors are based in San Diego, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Diego, US
Contact Information
Find more investors like Matt
Search Investors